He 2011a.
Study characteristics | |||
Patient sampling | The study was conducted in the respiratory intensive care unit (RICU) of Beijing Chao‐Yang Hospital, a teaching facility of the Capital Medical University in Beijing, China. Critically ill stage III or IV COPD patients were included. Samples of all patients included in this study were taken once a day for the first 3 days of their ICU stays and again once a week if the patient remained in the ICU for more than 7 days | ||
Patient characteristics and setting | COPD patients, thus high concern China |
||
Index tests | Consecutive serum samples for GM studies were collected on the first and the fourth days of the patient's admission to the ICU. A sandwich ELISA assay for GM detection (Platelia Aspergillus; Sanofi Diagnostics Pasteur, Marnes‐La‐Coquette, France) was used according to the manufacturer's instructions. An optical density (OD) ratio of 0.5 or greater was considered positive. Diagnosis was not based on a serum GM test |
||
Target condition and reference standard(s) | Based on case definitions of the EORTC/MSG, reference to De Pauw 2008. Thus, cases were interpreted as 'proven', 'probable' IPA or non‐IPA Patients from whom Aspergillus was recovered from non‐sterile sites, but who had no other evidence of fungal infections, were considered to be colonised. (ML: 'colonised' is not a classification that is mentioned in the original (2008) EORTC criteria) Diagnosis was not based on a serum GM test |
||
Flow and timing | Timing is unclear/not reported. All patients were classified according to EORTC criteria. Unclear whether all patients were included in analyses. No flow chart reported | ||
Comparative | |||
No patients per category | 90 patients; 1 proven and 18 probable | ||
Notes | No conflicts of interest declared or found | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Unclear | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Unclear | High | ||
DOMAIN 2: Index Test All tests | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Low | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Unclear | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Unclear | Unclear | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Unclear | ||
Unclear |